Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Docosahexaenoic acid and retinal function in children with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency.

× No keyword cloud information.

8 in total

1. Docosahexaenoic acid synthesis in human skin fibroblasts involves peroxisomal retroconversion of tetracosahexaenoic acid.

Authors: S A Moore; E Hurt; E Yoder; H Sprecher; A A Spector
Journal: J Lipid Res Date: 1995-11 Impact factor: 5.922

2. Ophthalmologic findings in long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency caused by the G1528C mutation: a new type of hereditary metabolic chorioretinopathy.

Authors: T Tyni; T Kivelä; M Lappi; P Summanen; E Nikoskelainen; H Pihko
Journal: Ophthalmology Date: 1998-05 Impact factor: 12.079

3. Proceedings: Polyunsaturated fatty acids of photoreceptor membranes.

Authors: R E Anderson; R M Benolken; P A Dudley; D J Landis; T G Wheeler
Journal: Exp Eye Res Date: 1974-03 Impact factor: 3.467

Review 4. On the molecular etiology of decreased arachidonic (20:4n-6), docosapentaenoic (22:5n-6) and docosahexaenoic (22:6n-3) acids in Zellweger syndrome and other peroxisomal disorders.

Authors: J P Infante; V A Huszagh
Journal: Mol Cell Biochem Date: 1997-03 Impact factor: 3.396

5. Dietary management of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (LCHADD). A case report and survey.

Authors: M Gillingham; S Van Calcar; D Ney; J Wolff; C Harding
Journal: J Inherit Metab Dis Date: 1999-04 Impact factor: 4.982

6. The molecular basis of pediatric long chain 3-hydroxyacyl-CoA dehydrogenase deficiency associated with maternal acute fatty liver of pregnancy.

Authors: H F Sims; J C Brackett; C K Powell; W R Treem; D E Hale; M J Bennett; B Gibson; S Shapiro; A W Strauss
Journal: Proc Natl Acad Sci U S A Date: 1995-01-31 Impact factor: 11.205

7. Biochemical and functional effects of prenatal and postnatal omega 3 fatty acid deficiency on retina and brain in rhesus monkeys.

Authors: M Neuringer; W E Connor; D S Lin; L Barstad; S Luck
Journal: Proc Natl Acad Sci U S A Date: 1986-06 Impact factor: 11.205

8. The metabolism of 7,10,13,16,19-docosapentaenoic acid to 4,7,10,13,16,19-docosahexaenoic acid in rat liver is independent of a 4-desaturase.

Authors: A Voss; M Reinhart; S Sankarappa; H Sprecher
Journal: J Biol Chem Date: 1991-10-25 Impact factor: 5.157

8 in total

11 in total

1. Effect of optimal dietary therapy upon visual function in children with long-chain 3-hydroxyacyl CoA dehydrogenase and trifunctional protein deficiency.

Authors: Melanie B Gillingham; Richard G Weleber; Martha Neuringer; William E Connor; Monte Mills; Sandy van Calcar; James Ver Hoeve; Jon Wolff; Cary O Harding
Journal: Mol Genet Metab Date: 2005-07-22 Impact factor: 4.797

2. A role for peroxisome proliferator-activated receptor γ coactivator 1 (PGC-1) in the regulation of cardiac mitochondrial phospholipid biosynthesis.

Authors: Ling Lai; Miao Wang; Ola J Martin; Teresa C Leone; Rick B Vega; Xianlin Han; Daniel P Kelly
Journal: J Biol Chem Date: 2013-12-11 Impact factor: 5.157

3. Polyunsaturated fatty acid deficiency during dietary treatment of very long-chain acyl-CoA dehydrogenase deficiency. Rescue with soybean oil.

Authors: J I Ruiz-Sanz; L Aldamiz-Echevarria; J Arrizabalaga; L Aquino; P Jimeno; G Pérez-Nanclares; P Sanjurjo
Journal: J Inherit Metab Dis Date: 2001-08 Impact factor: 4.982

Review 10. Systematic Review of Randomized Clinical Trials on Safety and Efficacy of Pharmacological and Nonpharmacological Treatments for Retinitis Pigmentosa.

Authors: Marta Sacchetti; Flavio Mantelli; Daniela Merlo; Alessandro Lambiase
Journal: J Ophthalmol Date: 2015-08-03 Impact factor: 1.909

Docosahexaenoic acid and retinal function in children with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency.

1. Docosahexaenoic acid synthesis in human skin fibroblasts involves peroxisomal retroconversion of tetracosahexaenoic acid.

2. Ophthalmologic findings in long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency caused by the G1528C mutation: a new type of hereditary metabolic chorioretinopathy.

3. Proceedings: Polyunsaturated fatty acids of photoreceptor membranes.

Review 4. On the molecular etiology of decreased arachidonic (20:4n-6), docosapentaenoic (22:5n-6) and docosahexaenoic (22:6n-3) acids in Zellweger syndrome and other peroxisomal disorders.

5. Dietary management of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (LCHADD). A case report and survey.

6. The molecular basis of pediatric long chain 3-hydroxyacyl-CoA dehydrogenase deficiency associated with maternal acute fatty liver of pregnancy.

7. Biochemical and functional effects of prenatal and postnatal omega 3 fatty acid deficiency on retina and brain in rhesus monkeys.

8. The metabolism of 7,10,13,16,19-docosapentaenoic acid to 4,7,10,13,16,19-docosahexaenoic acid in rat liver is independent of a 4-desaturase.

1. Effect of optimal dietary therapy upon visual function in children with long-chain 3-hydroxyacyl CoA dehydrogenase and trifunctional protein deficiency.

2. A role for peroxisome proliferator-activated receptor γ coactivator 1 (PGC-1) in the regulation of cardiac mitochondrial phospholipid biosynthesis.

3. Polyunsaturated fatty acid deficiency during dietary treatment of very long-chain acyl-CoA dehydrogenase deficiency. Rescue with soybean oil.

4. Long chain fatty acid oxidation defects in children: importance of detection and treatment options.

5. Mitochondrial Disease.

6. Plasma and erythrocyte fatty acid concentrations in long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency.

7. Neuropsychological Development in Patients with Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase (LCHAD) Deficiency.

8. Optimal dietary therapy of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency.

Review 9. Role of 3-Hydroxy Fatty Acid-Induced Hepatic Lipotoxicity in Acute Fatty Liver of Pregnancy.

Review 10. Systematic Review of Randomized Clinical Trials on Safety and Efficacy of Pharmacological and Nonpharmacological Treatments for Retinitis Pigmentosa.